Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-30

FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for zonisamide submitted by BluePoint Laboratories under ANDA 077651.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

SUPPL AP for ZONISAMIDE (ZONISAMIDE)